Lariquin 64.5/40 Mg Injection 30 Ml
30ml Injection in BottleMRP ₹17.85
₹13.39
25% OFF
Made by
THEMIS MEDICARE LTD
Dosage
INJECTION
Expiry
Product Summary
| Salt Content | Chloroquine(64.5 Mg) |
| Uses | Maleria |
| Therapy | Anti-malarial |
| Side effects | Blurred or foggy vision, eye damage, ringing in the ears or hearing loss, muscle weakness or numbness |
Assurance
available
Regulated
Medical Description
Lariquin injection is used to prevent and treat malaria. It contains chloroquine as an active ingredient. It works by entering infected cells and disrupting the growth and survival of parasites. In malaria, it builds up in the parasite and prevents it from processing blood properly, ultimately leading to its death. It can also help calm an overactive immune system in certain diseases by reducing inflammation and abnormal immune responses.
Lariquin injection is given by a doctor or nurse in a hospital or clinic, usually through an injection. You should not try to inject it yourself. After you receive the medicine, it is essential to follow the care instructions provided by your healthcare provider.
This medicine should not be used if you are allergic to it or similar medications or if you have a history of eye problems, especially those related to the retina. Common side effects include vision issues, stomach problems, muscle weakness, skin changes, mood swings, and changes in heartbeat or liver function. Always inform your doctor if you notice anything unusual.
Store the medicine in a cool, dry place, out of the reach of children. Since it’s given by a professional, missed doses or overdoses are rare. If you are pregnant or breastfeeding, your doctor will decide whether it’s safe for you. Avoid alcohol during treatment, and let your doctor know if you have vision issues or muscle problems or are travelling to areas where chloroquine may not work due to resistance.
Uses
Contraindications
- If you are allergic to chloroquine or any other ingredients of Lariquin injection.
- If you have any existing eye problems or vision changes, especially related to your retina or visual field.
- If you are allergic to any other 4-aminoquinoline medications (like hydroxychloroquine).
- If your doctor has previously found signs of eye damage from similar medicines.
Side effects
- Blurred or foggy vision
- Eye damage (can be permanent with long-term use)
- Ringing in the ears or hearing loss
- Muscle weakness or numbness
- Nausea, vomiting, or stomach pain
- Rash, itching, or peeling skin
- Hair loss or changes in hair or skin colour
- Mood changes (anxiety, confusion, hallucinations)
- Seizures or headaches
- Irregular heartbeat or low blood pressure
- Liver problems
- Blood disorders (like low red or white cells)
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You are travelling to or have malaria from areas where chloroquine may not work due to resistance.
- You have or have had vision problems, as chloroquine can cause serious eye damage.
- You have psoriasis or porphyria, as this medicine may exacerbate these conditions.
- You experience muscle weakness or unusual movements, as prolonged use can affect your muscles or nerves.
Directions for Use
Storage and disposal
- Store Lariquin injection below 25°C, protect it from direct sunlight.
- Do not store above 25°C or freeze.
- Keep it out of the reach of children and pets.
- Discard the unused medicine.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Frequently Asked Questions (FAQs)
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:LARIQUIN
Country of Origin:India
Vendor Details
Fulfillment Information: Lariquin 64.5 MG Injection (30) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- U.S. Food and Drug Administration. Aralen (chloroquine phosphate) tablets label. Reference ID: 3260349. Silver Spring (MD): FDA; 2013 [cited 2025 Jul 4].
- Central Drugs Standard Control Organisation. Drugs [Internet]. New Delhi: Ministry of Health and Family Welfare, Government of India; [cited 2025 Jul 4].
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.



















